Mean weight‐for‐age z‐score · children aged 6 to 23 months
1 finding from 1 review
Intervention not reported
Age of onset of independent walking (months) · children under six years with cerebral palsy or Down syndrome or at risk of neuromotor delay
1 finding from 1 review
Intervention not reported
Age of onset of walking with assistance (days in study) · children under six years with cerebral palsy or Down syndrome or at risk of neuromotor delay
1 finding from 1 review
Death during study period · adults with antisocial personality disorder
It is very uncertain whether psychosocial risk management ('Resettle' programme) changes adverse events: death during the study period Timing of assessment:… compared with treatment‐as‐usual (very low certainty).
1 finding from 1 review
ADHD symptoms · Children and adolescents with ADHD
It is very uncertain whether methylphenidate changes ADHD symptoms: all parallel‐group trials and first‐period cross‐over… compared with placebo or no intervention (very low certainty).
1 finding from 1 review
Children's percentage of total energy intake from saturated fat Measured by food frequency questionnaire and 24‐hour recall · children aged 7 to 18 years
1 finding from 1 review
Children's percentage of total energy intake from saturated fat Measured by food frequency questionnaire and 24‐hour recall · children aged 4 to 14 years
1 finding from 1 review
Children's percentage of total energy intake from saturated fat Measured by food frequency questionnaire and 24‐hour recall · children aged 3 to 11 years
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mobility · children with cerebral palsy classified within GMFCS Levels I to III between 5 and 19 years of age
1 finding from 1 review
Intervention not reported
Serious adverse events Measured by: proportion of serious adverse events (total) Average study duration (range): not stated · children and adolescents aged 18 years and under diagnosed with ADHD
It is very uncertain whether the intervention changes serious adverse events Measured by: proportion of serious adverse… (very low certainty).
1 finding from 1 review
Intervention not reported
Serious adverse events Measured by: proportion of any serious adverse events Average study duration (range): 4.7 months (14 days to 21 months) · children and adolescents aged 18 years and under diagnosed with ADHD
1 finding from 1 review
Intervention not reported
Withdrawal of methylphenidate due to serious adverse events (non‐comparative cohort studies) Measured by: proportion of participants withdrawn from treatment Average study duration (range): 7.9 months (1 month to 37 months) · children and adolescents aged 18 years and under diagnosed with ADHD
1 finding from 1 review
Intervention not reported
Withdrawal of methylphenidate due to adverse events of unknown severity Measured by: proportion of participants withdrawn from treatment Average study duration (range): 4.6 months (21 days to 36 months) · children and adolescents aged 18 years and under diagnosed with ADHD
1 finding from 1 review
Intervention not reported
Non‐serious adverse events Measured by: proportion of any non‐serious adverse events Average study duration (range): 5.99 months (1 day to 41 months) · children and adolescents aged 18 years and under diagnosed with ADHD
1 finding from 1 review
Intervention not reported
Withdrawal of methylphenidate due to non‐serious adverse events Measured by: proportion of participants withdrawn from treatment Average study duration (range): 5.60 months (0.6 months to 41 months) · children and adolescents aged 18 years and under diagnosed with ADHD
1 finding from 1 review
Intervention not reported
Withdrawal of methylphenidate for unknown reasons Measure by: proportion of participants withdrawn from treatment Average study duration (range): 6.13 months (1 day to 36 months) · children and adolescents aged 18 years and under diagnosed with ADHD
1 finding from 1 review
Speech and language function · children up to 5 years of age with a communication difficulty associated with any non‐progressive motor disorder acquired before 2 years…
1 finding from 1 review
Intervention not reported
Language ‐ joint (direct or independent assessment) EIDP/PSDP, PLS‐IV/CASL1 · children aged 1 year to 6 years 11 months with diagnosis of ASD
1 finding from 1 review
Intervention not reported
Language – expression (direct or independent assessment) PLS‐IV, MSEL1 · children aged 1 year to 6 years 11 months with diagnosis of ASD
1 finding from 1 review
Intervention not reported
Language – Comprehension (direct or independent assessment) PLS, MSEL1 · children aged 1 year to 6 years 11 months with diagnosis of ASD
1 finding from 1 review